These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 28556426)

  • 1. Retrospective study on the incidence and outcome of proven and probable invasive fungal infections in high-risk pediatric onco-hematological patients.
    Cesaro S; Tridello G; Castagnola E; Calore E; Carraro F; Mariotti I; Colombini A; Perruccio K; Decembrino N; Russo G; Maximova N; Baretta V; Caselli D
    Eur J Haematol; 2017 Sep; 99(3):240-248. PubMed ID: 28556426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
    Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
    Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.
    Kurosawa M; Yonezumi M; Hashino S; Tanaka J; Nishio M; Kaneda M; Ota S; Koda K; Suzuki N; Yoshida M; Hirayama Y; Takimoto R; Torimoto Y; Mori A; Takahashi T; Iizuka S; Ishida T; Kobayashi R; Oda T; Sakai H; Yamamoto S; Takahashi F; Fukuhara T
    Int J Hematol; 2012 Dec; 96(6):748-57. PubMed ID: 23111539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders.
    Qiu KY; Liao XY; Fang JP; Xu HG; Li Y; Huang K; Zhou DH
    Transpl Infect Dis; 2019 Jun; 21(3):e13066. PubMed ID: 30859662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years.
    Hovi L; Saarinen-Pihkala UM; Vettenranta K; Saxen H
    Bone Marrow Transplant; 2000 Nov; 26(9):999-1004. PubMed ID: 11100280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.
    De la Serna J; Jarque I; López-Jiménez J; Fernández-Navarro JM; Gómez V; Jurado M; Pascual A; Serrano J; Romero M; Vallejo C
    Rev Esp Quimioter; 2013 Mar; 26(1):64-9. PubMed ID: 23546466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation.
    Dvorak CC; Steinbach WJ; Brown JM; Agarwal R
    Bone Marrow Transplant; 2005 Oct; 36(7):621-9. PubMed ID: 16044133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary antifungal prophylaxis in hematological malignancy patients with previous invasive fungal disease: a retrospective analysis.
    Liu M; Li Y; Zhang Y; Zhao X; Zhai B; Zhang Q; Wang L; Zhao Y; Li H; Wang Q; Gao C; Huang W; Yu L
    PLoS One; 2014; 9(12):e115461. PubMed ID: 25531544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prophylaxis use of posaconazole (P) in an hemato-oncology unit: a retrospective study].
    Selvy N; Villiet M; Hansel-Esteller S
    Pathol Biol (Paris); 2010 Apr; 58(2):123-6. PubMed ID: 19864087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Efficacy and Safety of Caspofungin Versus Micafungin in Pediatric Allogeneic Stem Cell Transplant Recipients: A Retrospective Analysis.
    Maximova N; Schillani G; Simeone R; Maestro A; Zanon D
    Adv Ther; 2017 May; 34(5):1184-1199. PubMed ID: 28429246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proven and probable invasive fungal infections in children with acute lymphoblastic leukaemia: results from an university hospital, 2005-2013.
    Sahbudak Bal Z; Yilmaz Karapinar D; Karadas N; Sen S; Onder Sivis Z; Akinci AB; Balkan C; Kavakli K; Vardar F; Aydinok Y
    Mycoses; 2015 Apr; 58(4):225-32. PubMed ID: 25728069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive fungal infections in children with hematologic and malignant diseases.
    Ozsevik SN; Sensoy G; Karli A; Albayrak C; Dagdemir A; Belet N; Elli M; Fisgin T; Ozyurek E; Duru F; Albayrak D
    J Pediatr Hematol Oncol; 2015 Mar; 37(2):e69-72. PubMed ID: 25072372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence and risk factors of invasive fungal infection after haploidentical haematopoietic stem cell transplantation without in vitro T-cell depletion.
    Sun YQ; Xu LP; Liu DH; Zhang XH; Chen YH; Chen H; Ji Y; Wang Y; Han W; Wang JZ; Wang FR; Liu KY; Huang XJ
    Clin Microbiol Infect; 2012 Oct; 18(10):997-1003. PubMed ID: 22085092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients.
    Jantunen E; Salonen J; Juvonen E; Koivunen E; Siitonen T; Lehtinen T; Kuittinen O; Leppä S; Anttila VJ; Itälä M; Wiklund T; Remes K; Nousiainen T
    Eur J Haematol; 2004 Sep; 73(3):174-8. PubMed ID: 15287914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.
    Auberger J; Lass-Flörl C; Ulmer H; Nogler-Semenitz E; Clausen J; Gunsilius E; Einsele H; Gastl G; Nachbaur D
    Int J Hematol; 2008 Dec; 88(5):508-515. PubMed ID: 18982251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical feature of invasive fungal infection in pediatric patients with hematologic and malignant diseases: a 10-year analysis at a single institution at Japan.
    Kobayashi R; Kaneda M; Sato T; Ichikawa M; Suzuki D; Ariga T
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):886-90. PubMed ID: 19131772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prevalence and risk factors of invasive fungal infection in hematopoietic stem cell transplant recipients].
    Xu LP; Ji Y; Liu DH; Chen YH; Han W; Liu KY; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2007 Jun; 46(6):486-9. PubMed ID: 17663826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogenic Hematopoietic Stem Cell Transplantation Is Feasible in Pediatric Patients with an Active or Recently Diagnosed Invasive Fungal Infection.
    Rotte LGY; Loeffen YGT; Bierings MB; Wolfs TFW; Lindemans CA
    Transplant Cell Ther; 2021 Sep; 27(9):781.e1-781.e5. PubMed ID: 34153502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.